Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance?

By sjmartinez • June 21, 2023

Chester RC, Parikh RV. Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance? Circ Cardiovasc Interv. 2023 Jun;16(6):e013113. doi: 10.1161/CIRCINTERVENTIONS.123.013113. Epub 2023 Jun 20. PMID: 37339236.

Tags: angiography, Cardiology/Epi, coronary artery disease, drug-eluting stents, Editorials, percutaneous coronary intervention, Publications

Metabolomics-Based Investigation of PFOS-Induced Molecular Perturbations Across Multiple Rat Organs

Yen TH, Lee SH, Liang HJ, Huang ZX, Chen CT, Li C, Lin CY. Metabolomics-Based Investigation of PFOS-Induced Molecular Perturbations Across Multiple Rat Organs. Environ[...]

Trimethylamine N-oxide and related metabolites may regulate DNA methylation and trigger cardiovascular disease

Ma J, Lai CQ, Li XS, Wang M, Wang Z, Yao J, Guo X, Taylor KD, Lee S, Tracy RP, Peter D, Liu Y, Rotter[...]

Transcatheter Pulmonary Valve Implantation With the Alterra Adaptive Prestent and SAPIEN 3 Transcatheter Heart Valve: 3-Year Pooled Outcomes of the ALTERRA Trials

Torres AJ, Dimas VV, Shahanavaz S, Balzer D, Morgan G, Lim DS, Armstrong AK, Berman D, Babaliaros V, Kim D, Gillespie MJ, Sommer R, Aboulhosn[...]